Unrecognized Renal Transplants as a Potential Source of False-Positive Interpretation of FDG PET
- 1 August 2003
- journal article
- Published by Wolters Kluwer Health in Clinical Nuclear Medicine
- Vol. 28 (8) , 655-657
- https://doi.org/10.1097/01.rlu.0000079429.00677.c1
Abstract
Renal transplantation has become an effective therapy for patients with late-stage renal disease. Fluorodeoxyglucose (FDG) positron emission tomography (PET) is accepted as an important diagnostic technique in the evaluation of suspected or known malignancies or other disorders in the day-to-day practice of medicine. Because FDG is excreted from the kidneys into the urine, unrecognized renal transplants can appear as malignant lesions. Familiarity with the clinical history is a prerequisite in the correct interpretation of FDG PET images in this setting. In addition, FDG PET images should be correlated with anatomic images when such studies are available. When neither clinical history nor anatomic images are available, a combination of "abnormal" activity in the pelvis and absence of normal renal activity should raise suspicion of the existence of a renal transplant.Keywords
This publication has 7 references indexed in Scilit:
- Pelvic Kidney Mimicking Recurrent Colon Cancer on FDG Positron Emission Tomographic ImagingClinical Nuclear Medicine, 2002
- Whole-body FDG-PET imaging in the management of patients with cancerSeminars in Nuclear Medicine, 2002
- 18-Fluorodeoxyglucose positron emission tomographic imaging in the detection and monitoring of infection and inflammationSeminars in Nuclear Medicine, 2002
- Horseshoe Kidney on FDG Positron Emission Tomographic Imaging Is Easily Confused with MalignancyClinical Nuclear Medicine, 2001
- Standardized Uptake Value as an Unreliable Index of Renal Disease on Fluorodeoxyglucose PET ImagingClinical Nuclear Medicine, 2000
- Normal variants, artefacts and interpretative pitfalls in PET imaging with 18-fluoro-2-deoxyglucose and carbon-11 methionineEuropean Journal of Nuclear Medicine and Molecular Imaging, 1999
- Oncological applications of positron emission tomography with fluorine-18 fluorodeoxyglucoseEuropean Journal of Nuclear Medicine and Molecular Imaging, 1996